发明名称 PHARMACEUTICAL COMPOSITION
摘要 <p><P>PROBLEM TO BE SOLVED: To obtain an excellent high-conductance type calcium-sensitive K-channel opening drug. <P>SOLUTION: For producing the high-conductance type calcium-sensitive K-channel opening drug, a five-membered heterocyclic compound of formula(II) or a pharmacologically acceptable salt thereof is used. In formula(II), ring A is a ring represented by either of formula A; R<SP>1</SP>is a substituted or unsubstituted aryl, a substituted or unsubstituted heterocyclic group or a substituted or unsubstituted heterocyclic group-substituted carbonyl; R<SP>2</SP>is a substituted alkyl; R<SP>3</SP>is a substituted or unsubstituted aryl, a substituted or unsubstituted heterocyclic group or a substituted or unsubstituted alkyl; and R<SP>4</SP>is H or a substituted or unsubstituted alkyl; wherein, when R<SP>1</SP>and R<SP>3</SP>are each phenyl, R<SP>2</SP>is neither carboxymethyl nor ethoxycarbonylmethyl. <P>COPYRIGHT: (C)2006,JPO&NCIPI</p>
申请公布号 JP2005325103(A) 申请公布日期 2005.11.24
申请号 JP20050115251 申请日期 2005.04.13
申请人 TANABE SEIYAKU CO LTD 发明人 HOSAKA TOSHIHIRO;KUSAMA MARI;OBA KIYOMI;KOUNO RIKAKO;KONOUMI SHUNTARO
分类号 C07D333/24;A61K31/343;A61K31/381;A61K31/4025;A61K31/443;A61K31/4436;A61P1/04;A61P3/10;A61P9/00;A61P9/04;A61P9/10;A61P9/12;A61P11/00;A61P11/06;A61P13/00;A61P13/04;A61P15/00;A61P15/10;A61P17/14;A61P25/22;C07D307/54;C07D333/28;C07D405/04;C07D409/04;C07D409/14;(IPC1-7):A61K31/343;A61K31/402 主分类号 C07D333/24
代理机构 代理人
主权项
地址